|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 132.00 JPY | 0.00% |
|
-2.22% | -0.75% |
| 23-12-13 | Eisai to launch Alzheimer's drug Leqembi in Japan on Dec 20 | RE |
| 23-12-08 | Toshiba, Rohm to Invest $2.69 Billion to Make Power Devices in Boost to Japan Chip Industry | DJ |
| Fiscal Period: February | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 44.07B | 44.46B | 44.06B | 43.56B | 43.52B | |||||
Total Revenues | 44.07B | 44.46B | 44.06B | 43.56B | 43.52B | |||||
Cost of Goods Sold, Total | 39.2B | 39B | 38.65B | 38.26B | 38.28B | |||||
Gross Profit | 4.87B | 5.46B | 5.41B | 5.29B | 5.24B | |||||
Selling General & Admin Expenses, Total | 4.38B | 4.57B | 4.91B | 4.83B | 4.84B | |||||
Provision for Bad Debts | - | - | - | 1M | - | |||||
Other Operating Expenses, Total | 4.38B | 4.57B | 4.91B | 4.83B | 4.84B | |||||
Operating Income | 490M | 887M | 506M | 464M | 405M | |||||
Interest Expense, Total | -2M | -3M | -4M | -6M | -4M | |||||
Interest And Investment Income | 8M | 7M | 12M | 14M | 19M | |||||
Net Interest Expenses | 6M | 4M | 8M | 8M | 15M | |||||
Income (Loss) On Equity Invest. | 11M | 26M | 21M | 18M | 19M | |||||
Currency Exchange Gains (Loss) | - | 8M | 12M | 4M | - | |||||
Other Non Operating Income (Expenses) | 161M | 8M | 7M | 9M | 14M | |||||
EBT, Excl. Unusual Items | 668M | 933M | 554M | 503M | 453M | |||||
Gain (Loss) On Sale Of Investments | - | 159M | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | -1M | -2M | -1M | - | |||||
Asset Writedown | - | - | -13M | - | - | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | 668M | 1.09B | 539M | 502M | 453M | |||||
Income Tax Expense | 220M | 359M | 194M | 188M | 169M | |||||
Earnings From Continuing Operations | 448M | 732M | 345M | 314M | 284M | |||||
Net Income to Company | 448M | 732M | 345M | 314M | 284M | |||||
Net Income - (IS) | 448M | 732M | 345M | 314M | 284M | |||||
Net Income to Common Incl Extra Items | 448M | 732M | 345M | 314M | 284M | |||||
Net Income to Common Excl. Extra Items | 448M | 732M | 345M | 314M | 284M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 8.18 | 13.37 | 6.3 | 5.73 | 5.19 | |||||
Basic EPS - Continuing Operations | 8.18 | 13.37 | 6.3 | 5.73 | 5.19 | |||||
Basic Weighted Average Shares Outstanding | 54.76M | 54.76M | 54.76M | 54.76M | 54.76M | |||||
Net EPS - Diluted | 8.18 | 13.37 | 6.3 | 5.73 | 5.19 | |||||
Diluted EPS - Continuing Operations | 8.18 | 13.37 | 6.3 | 5.73 | 5.19 | |||||
Diluted Weighted Average Shares Outstanding | 54.76M | 54.76M | 54.76M | 54.76M | 54.76M | |||||
Normalized Basic EPS | 7.62 | 10.65 | 6.32 | 5.74 | 5.17 | |||||
Normalized Diluted EPS | 7.62 | 10.65 | 6.32 | 5.74 | 5.17 | |||||
Dividend Per Share | 3 | 4 | 4 | 4 | 4 | |||||
Payout Ratio | 24.33 | 22.4 | 63.19 | 69.75 | 77.11 | |||||
Supplemental Items | ||||||||||
EBITDA | 691M | 1.15B | 801M | 814M | 769M | |||||
EBITA | 490M | 887M | 506M | 464M | 405M | |||||
EBIT | 490M | 887M | 506M | 464M | 405M | |||||
EBITDAR | 1.1B | 1.56B | 1.3B | 1.28B | - | |||||
Effective Tax Rate - (Ratio) | 32.93 | 32.91 | 35.99 | 37.45 | 37.31 | |||||
Normalized Net Income | 418M | 583M | 346M | 314M | 283M | |||||
Non-Cash Pension Expense | -19M | -22M | -8M | -6M | -3M | |||||
Supplemental Operating Expense Items | ||||||||||
Net Rental Expense, Total | 408M | 413M | 499M | 467M | - | |||||
Imputed Operating Lease Interest Expense | 11.18M | 18.59M | 25.92M | 47.24M | - | |||||
Imputed Operating Lease Depreciation | 397M | 394M | 473M | 420M | - |
- Stock Market
- Stocks
- 7624 Stock
- Financials Naito & Co., Ltd.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















